Immunotherapy, intralesional treatments, multidisciplinary care teams define rapidly-evolving multimodal approach.
Archive | Of Interest
Apatinib Prompts Responses in Patients With Recurrent Melanoma
The drug yielded partial responses in 2 of 15 patients in this single-arm, phase 2 study.
Posted in Melanoma News, Health Professionals, Of Interest
Multiple Myeloma May Increase Incidence of Melanoma
Patients with multiple myeloma (MM) may be more likely to develop melanoma than the general population, according to a poster presented at 2022 American College of Mohs Surgery Annual Meeting. They also may face a higher overall but not melanomas-specific mortality rate, the findings showed.
Posted in Melanoma News, Health Professionals, Of Interest
How to Ensure Outdoor Workers Use Sun Protection
Sunscreen use is on the rise, but further education is needed.
Posted in Melanoma News, Health Professionals, Of Interest
 |
 |
 |
 |
